Case Report

Solitary Recurrent Metastasis of Squamous Cell Carcinoma of the Uterine Cervix in the Spleen: Case Report

Authors: Leou Chuan Pang, MD

Abstract

In cervical squamous cell carcinoma, solitary metastasis to and recurrence in the parenchyma of the spleen are uncommon in the absence of apparent disease in other sites. A case of a 50-year-old patient with a Stage IIa carcinoma of the cervix treated with radical hysterectomy and pelvic lymphadenectomy followed by radiotherapy is reported. Serial squamous cell carcinoma (SCC) antigen measurements have been performed for monitoring the course of disease, response to treatment, and detection of tumor recurrence. Recurrent disease was initially suspected on the basis of an elevated SCC level, 7.11 μg/ml (normal, < 1.5 μg/ml), subsequently confirmed by computed tomographic scan, magnetic resonance imaging, and positron emission tomography of the abdomen and pelvis. Laparoscopic splenectomy followed by chemotherapy with cisplatin was performed. The SCC antigen level was within normal limits postoperatively. The patient was well and clinically free of disease for 5 months.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Ngan HY, Wong LC, Chan SY, et al. Use of serum squamous cell carcinoma antigen assays in chemotherapy treatment of cervical cancer. Gynecol Oncol 1989; 35: 259–262.
 
2. Ngan HY, Chan SY, Wong LC, et al. Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix. Gynecol Oncol 1990; 37: 260–263.
 
3. Brioschi PA, Bischof P, Delafosse C, et al. Squamous cell carcinoma antigen (SCC-A) values related to clinical outcome of preinvasive and invasive cervical carcinoma. Int J Cancer 1991; 47: 376–379.
 
4. Holloway RW, To A, Moradi M, et al. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay. Obstet Gynecol 1989; 74: 944–947.
 
5. Carvalho L, Azevedo I, Salgado L, et al. Squamous cell carcinoma of the cervix metastatic to the spleen: Case report. Gynecol Oncol 1997; 67: 107–110.
 
6. Carlson V, Delclo L, Fletcher GH. Distant metastases in squamous cell carcinoma of the uterine cervix. Radiology 1967; 88: 961–966.
 
7. Sotto LSJ, Graham JB, Pickren JW. Postmortem findings in cancer of the cervix. Am J Obstet Gynecol 1960; 80: 791–794.
 
8. Badib AO, Kurohara SS, Webster JH, et al. Metastasis to organs in carcinoma of the uterine cervix: Influence of treatment on incidence and distribution. Cancer 1968; 21: 434–439.
 
9. Lam KY, Tang V. Metastatic tumors to the spleen. Arch Pathol Lab Med 2000; 124: 526–530.
 
10. Chan YM, Ng TY, Ngan HY, et al. Monitoring of serum squamous cell carcinoma antigen levels in invasive cervical cancer: Is it cost effective? Gynecol Oncol 2001; 84: 7–11.